If you or someone you care about has been diagnosed with an atypical Parkinsonian disorder such as Lewy body dementia (LBD), progressive supranuclear palsy (PSP), corticobasal syndrome (CBS) or multiple system atrophy (MSA), the team at the Parkinson's Disease and Movement Disorders Center can provide expert clinical evaluation and offer the most current and effective treatments.

Dr. Alexander Pantelyat, Director of the Atypical Parkinsonism Center at Johns Hopkins.

Atypical Parkinsonism Treatment: Why Choose Johns Hopkins

• The Atypical Parkinsonism Center at Johns Hopkins, one of only a handful of such clinics around the world, is dedicated to treating these disorders.
• Although atypical Parkinsonism is rare in the general population, our doctors have years of experience researching, assessing and managing it.
• By developing a highly personalized multidisciplinary model of care, we help all patients make the most of their abilities.
• Our doctors discuss each patient’s case at a monthly clinic, and confer on the latest research and clinical understanding.
• As a major research center for atypical Parkinsonism, our clinic can direct patients to participation opportunities in clinical trials.

Atypical Parkinsonism Treatment at Johns Hopkins: What to Expect

Your assessment at Johns Hopkins includes time with a neurologist specializing in atypical Parkinsonism, as well as experts in physical therapy, cognitive (thinking) challenges, speech and swallowing, and social work.

Atypical Parkinsonism disorders can affect a person’s life in many ways. At Johns Hopkins, we listen closely to understand how your condition is affecting your life. Together, we work with you on a treatment approach designed to slow progression and improve your well-being.

Our Research

Atypical Parkinsonism experts and researchers Dr. Alexander Pantelyat and Dr. Jee Bang.

Johns Hopkins is proud to be a Lewy Body Dementia Association research center of excellence, combining the expertise of several team specializing in research and treatment of memory disorders and Alzheimer’s disease, atypical Parkinsonism, frontotemporal dementia, young-onset dementias and Parkinson’s disease.

Jee Bang, M.D., M.P.H. and her team conduct clinical trials in multiple systems atrophy (MSA) and other atypical Parkinsonisms.